KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Return on Equity (2016 - 2025)

LifeMD's Return on Equity history spans 13 years, with the latest figure at 0.68% for Q4 2025.

  • For Q4 2025, Return on Equity fell 467.0% year-over-year to 0.68%; the TTM value through Dec 2025 reached 0.68%, down 467.0%, while the annual FY2025 figure was 3.15%, 420.0% up from the prior year.
  • Return on Equity reached 0.68% in Q4 2025 per LFMD's latest filing, up from 3.59% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 26.22% in Q1 2021 to a low of 92.83% in Q3 2022.
  • Average Return on Equity over 5 years is 8.09%, with a median of 1.04% recorded in 2023.
  • Peak YoY movement for Return on Equity: tumbled -9859bps in 2022, then surged 9477bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 40.21% in 2021, then surged by 117bps to 6.76% in 2022, then fell by -27bps to 4.96% in 2023, then decreased by -20bps to 3.99% in 2024, then tumbled by -117bps to 0.68% in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Return on Equity are 0.68% (Q4 2025), 3.59% (Q3 2025), and 0.1% (Q2 2025).